In Hsf1 Activators Lower cardiomyocyte damage: Towards a novel therapeutic approach to REVERSE atrial fibrillation (HALT & REVERSE), we will focus on the electropathological substrate of AF and dissect the mechanism of protection. The gene discussed is HSF1; the disease is atrial fibrillation.